Prospects and RISC score of viral gene therapy for sarcoma

Author： Fruehauf S   Veldwijk MR   Zeller WJ   Laufs S  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.8, 2003-12, pp. : 1241-1251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy strategies for the treatment of chronic viral hepatitis

By Lollo Charles P   Banaszczyk Mariusz G   Ill Charles R   Coffin Christopher C   Lucas Michael A   Chiou Henry C  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 629-639

Informa Healthcare

Access to resources Recommend Favorite

Non-viral gene transfer therapy for cystic fibrosis

By Ziady Assem G   Davis Pamela B   Konstan Michael W  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Non-viral delivery of ribozymes for cancer gene therapy

By Kashani-Sabet Mohammed  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1749-1755

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for pulmonary hypertension: prospects and challenges

By Reynolds Paul N  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 2, 2011-02 ,pp. : 133-143

Informa Healthcare

Access to resources Recommend Favorite

Intravenous, non-viral RNAi gene therapy of brain cancer

By Pardridge William M  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1103-1113

Informa Healthcare

Access to resources Recommend Favorite